Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1980 Aug;40(4):495–503.

NK activity in carrageenan-treated mice.

P C Quan, J P Kolb, G Lespinats
PMCID: PMC1458092  PMID: 6159311

Abstract

NK activity was determined by measuring 51chromium released from Yac-1 target cells incubated with spleen cells from normal or carrageenan (Car)-treated mice. Intraperitoneal administration of a single dose of i-Car (3 mg) provoked splenomegaly in mice. This splenomegaly accompanied during the first days (2-3), a marked increase of NK activity, then a decrease of this activity at day 8-9. It was returned to normal level at day 30. The modulation of NK activity in Car-treated mice is not due to the variation of the number of NK cells, since the frequency of target-binding cells (TBC) was not modified. The increase in NK activity during the first days may be due to the presence of interferon induced by carrageenan. Concomitant injection of an anti-mouse interferon globulin with carrageenan abolished the boosting of NK activity. NK activity of spleen cells from Car-treated mice at day 8 could not be stimulated by interferon in vitro as it could with the normal spleen cells. No decrease of NK activity was observed in Car-treated mice at day 8, when indomethacin was administered. Hence the decrease of this activity in Car-8 mice might be partially due to the alteration of NK effector cells induced by prostaglandins.

Full text

PDF
495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Harington J. S., Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med. 1966 Aug 1;124(2):141–154. doi: 10.1084/jem.124.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Catalona W. J., Ratliff T. L., McCool R. E. Effects of carrageenan on spontaneous and antibody-dependent cell-mediated cytotoxicity. Cell Immunol. 1978 Sep 15;40(1):1–15. doi: 10.1016/0008-8749(78)90310-6. [DOI] [PubMed] [Google Scholar]
  3. Catanzaro P. J., Schwartz H. J., Graham R. C., Jr Spectrum and possible mechanism of carrageenan cytotoxicity. Am J Pathol. 1971 Aug;64(2):387–404. [PMC free article] [PubMed] [Google Scholar]
  4. Cikes M., Friberg S., Jr, Klein G. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst. 1973 Feb;50(2):347–362. doi: 10.1093/jnci/50.2.347. [DOI] [PubMed] [Google Scholar]
  5. Cudkowicz G., Hochman P. S. Do natural killer cells engage in regulated reactions against self to ensure homeostasis? Immunol Rev. 1979;44:13–41. doi: 10.1111/j.1600-065x.1979.tb00266.x. [DOI] [PubMed] [Google Scholar]
  6. Cudkowicz G., Yung Y. P. Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan. J Immunol. 1977 Aug;119(2):483–487. [PubMed] [Google Scholar]
  7. DAVIES G. E. INHIBITION OF COMPLEMENT BY CARRAGEENIN: MODE OF ACTION, EFFECT ON ALLERGIC REACTIONS AND ON COMPLEMENT OF VARIOUS SPECIES. Immunology. 1965 Mar;8:291–299. [PMC free article] [PubMed] [Google Scholar]
  8. DAVIES G. E. INHIBITION OF GUINEA-PIG COMPLEMENT IN VITRO AND IN VIVO BY CARRAGEENIN. Immunology. 1963 Nov;6:561–568. [PMC free article] [PubMed] [Google Scholar]
  9. Di Rosa M. Biological properties of carrageenan. J Pharm Pharmacol. 1972 Feb;24(2):89–102. doi: 10.1111/j.2042-7158.1972.tb08940.x. [DOI] [PubMed] [Google Scholar]
  10. Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon. J Immunol. 1979 Jan;122(1):182–188. [PubMed] [Google Scholar]
  11. Droller M. J., Perlmann P., Schneider M. U. Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol. 1978 Aug;39(1):154–164. doi: 10.1016/0008-8749(78)90090-4. [DOI] [PubMed] [Google Scholar]
  12. Droller M. J., Schneider M. U., Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol. 1978 Aug;39(1):165–177. doi: 10.1016/0008-8749(78)90091-6. [DOI] [PubMed] [Google Scholar]
  13. Gemsa D., Seitz M., Kramer W., Till G., Resch K. The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol. 1978 Apr;120(4):1187–1194. [PubMed] [Google Scholar]
  14. Gordon D., Bray M. A., Morley J. Control of lymphokine secretion by prostaglandins. Nature. 1976 Jul 29;262(5567):401–402. doi: 10.1038/262401a0. [DOI] [PubMed] [Google Scholar]
  15. Gresser I., Bandu M. T., Brouty-Boyé D. Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. J Natl Cancer Inst. 1974 Feb;52(2):553–559. doi: 10.1093/jnci/52.2.553. [DOI] [PubMed] [Google Scholar]
  16. Gresser I., Fontaine-Brouty-Boyé D., Bourali C., Thomas M. T. A comparison of the efficacy of endogenous, exogenous, and combined endogenous-exogenous interferon in the treatment of mice infected with encephalomyocarditis virus. Proc Soc Exp Biol Med. 1969 Jan;130(1):236–242. doi: 10.3181/00379727-130-33529. [DOI] [PubMed] [Google Scholar]
  17. Gresser I., Tovey M. G., Bandu M. E., Maury C., Brouty-Boyé D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med. 1976 Nov 2;144(5):1305–1315. doi: 10.1084/jem.144.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Herberman R. B., Nunn M. E., Holden H. T. Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol. 1978 Jul;121(1):304–309. [PubMed] [Google Scholar]
  19. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  20. Keller R. Promotion of tumor growth in vivo by antimacrophage agents. J Natl Cancer Inst. 1976 Dec;57(6):1355–1361. doi: 10.1093/jnci/57.6.1355. [DOI] [PubMed] [Google Scholar]
  21. Kiessling R., Hochman P. S., Haller O., Shearer G. M., Wigzell H., Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol. 1977 Sep;7(9):655–663. doi: 10.1002/eji.1830070915. [DOI] [PubMed] [Google Scholar]
  22. London J., Berrih S., Bach J. F. Peanut agglutinin. I. A new tool for studying T lymphocyte subpopulations. J Immunol. 1978 Aug;121(2):438–443. [PubMed] [Google Scholar]
  23. Lotzova E., Gallagher M. T., Trentin J. J. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica. Biomedicine. 1975 Sep;22(5):387–392. [PubMed] [Google Scholar]
  24. Lotzová E., Richie E. R. Promotion of incidence of adenovirus type 12 transplantable tumors by carrageenan, a specific antimacrophage agent. J Natl Cancer Inst. 1977 Apr;58(4):1171–1172. doi: 10.1093/jnci/58.4.1171. [DOI] [PubMed] [Google Scholar]
  25. Rios A., Simmons R. L. Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan. Transplantation. 1972 Mar;13(3):343–345. doi: 10.1097/00007890-197203000-00026. [DOI] [PubMed] [Google Scholar]
  26. Roder J. C., Kiessling R., Biberfeld P., Andersson B. Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol. 1978 Dec;121(6):2509–2517. [PubMed] [Google Scholar]
  27. Roder J. C., Kiessling R. Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. Scand J Immunol. 1978;8(2):135–144. doi: 10.1111/j.1365-3083.1978.tb00505.x. [DOI] [PubMed] [Google Scholar]
  28. Rumjanek V. M., Brent L. Immunosuppressive activity of carrageenan for cell-mediated responses in the mouse. Transplantation. 1978 Aug;26(2):113–118. doi: 10.1097/00007890-197808000-00011. [DOI] [PubMed] [Google Scholar]
  29. Schwartz H. J., Kellermeyer R. W. Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance. Proc Soc Exp Biol Med. 1969 Dec;132(3):1021–1024. doi: 10.3181/00379727-132-34358. [DOI] [PubMed] [Google Scholar]
  30. Stockman G. D., Mumford D. M. The effect of prostaglandins on the in vitro blastogenic response of human peripheral blood lymphocytes. Exp Hematol. 1974;2(2):65–72. [PubMed] [Google Scholar]
  31. Thomson A. W., Horne C. H. Toxicity of various carrageenans in the mouse. Br J Exp Pathol. 1976 Aug;57(4):455–459. [PMC free article] [PubMed] [Google Scholar]
  32. Tovey M. G., Begon-Lours J., Gresser I. A method for the large scale production of potent interferon preparations. Proc Soc Exp Biol Med. 1974 Jul;146(3):809–815. doi: 10.3181/00379727-146-38196. [DOI] [PubMed] [Google Scholar]
  33. Velo G. P., Dunn C. J., Giroud J. P., Timsit J., Willoughby D. A. Distribution of prostaglandins in inflammatory exudate. J Pathol. 1973 Nov;111(3):149–158. doi: 10.1002/path.1711110302. [DOI] [PubMed] [Google Scholar]
  34. Yung Y. P., Cudkowicz G. Abrogation of resistance to foreign bone marrow grafts by carrageenans. II. Studies with the anti-macrophage agents iota, kappa, and lambda-carrageenans. J Immunol. 1977 Oct;119(4):1310–1315. [PubMed] [Google Scholar]
  35. Yung Y. P., Cudkowicz G. Suppression of cytotoxic T lymphocytes by carrageenan-activated macrophage-like cells. J Immunol. 1978 Nov;121(5):1990–1997. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES